All Insights
Showing 1 - 12 of 617
Life Sciences and Healthcare
Planned EU medtech changes and codified Helsinki procedure support consistent qualification and classification
EU coordination, expert panel opinions and targeted down classification are proposed to harmonise risk based outcomes
Corporate
Confidence in a changing global market: 2025 dealmaking themes and 2026 market opportunities
The global transactional market demonstrated resilience amid complexity in 2025 as it staged a measured recovery
Life Sciences and Healthcare
EU drug agency to take broader coordinating role in devices and diagnostics in latest proposal
Expert panel support, shortage coordination and combined study procedures strengthen the EMA's oversight of devices
Intellectual property
What does 2026 augur for AI and IP in Europe?
AI and copyright appeals set to take centre stage, with a consultation response promised from the UK government and a
Life Sciences and Healthcare
Revised EU medtech regulations proposal sharpens software and cybersecurity rules for digital health
Down‑classification, established software concepts and cyber-incident reporting could reshape digital medtech compliance
Regulatory Outlook
Fintech, digital assets, payments and consumer credit | UK Regulatory Outlook January 2026
Fintech: FCA approach to AI regulation | Artificial Intelligence (Regulation) Bill reintroduced to Parliament Digital Assets: Cryptoassets regulation moves closer
Regulatory Outlook
Digital regulation | UK Regulatory Outlook January 2026
UK Online Safety Act: fees, categorisation and enforcement | UK Media Act: a year dense with 'go‑live' dates | EU
Regulatory Outlook
Cyber security | UK Regulatory Outlook January 2026
The Cyber Security and Resilience Bill | Cyber essentials supply chain playbook | Government cyber security strategy
Life Sciences and Healthcare
Proposed EU medtech laws seek more predictable and efficient notified body oversight
Structured dialogue, streamlined sampling, extended audits and SME‑friendly fees to reshape device conformity assessment
Life Sciences and Healthcare
EU revised device rules rebalance compliance towards simplification and proportionality
Commission proposal would streamline MDR and IVDR duties with flexible evidence, timeless certificates and tailored risk rules
Knowledge Notes
What business law changes can the UK expect in 2026?
Osborne Clarke's Knowledge Team looks at what's in store for business
Intellectual property
Cross-border IP infringement: European perspectives on foreign use of IP rights online
How are intellectual property rights enforced when businesses sell goods online across international borders?
